British pharmaceutical giant AstraZeneca said Tuesday that its net profit jumped 45 percent last year on strong sales of cancer drugs, as it expands its reach in the United States ...

There is a history of studying relaxin in cardiovascular settings—Novartis started a phase 3 heart failure trial of a recombinant relaxin-2 peptide in 2013—but preclinical evidence of the molecule’s ...

AstraZeneca has made major moves to grow in ‌the United States and China, its top two markets, with a $50 ​billion ‌U.S. manufacturing deal last ‍year, ⁠an NYSE listing and a $15 billion China ...

AstraZeneca on Tuesday announced fourth-quarter profit in line with expectations on demand for its cancer and heart drugs. The pharmaceutical company (AZN) (UK:AZN) said its core earnings per share ...

President Donald Trump's new prescription drug website, TrumpRx.gov, is focused largely on the significant discounts the ...

Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...

Trump launched TrumpRx, a new website offering discounted prescription medicines. See how to use it, which drugs are included ...

TrumpRx, the Trump administration’s much-anticipated direct-to-consumer drug platform, went live on Thursday. However, it remains to be seen whether direct-to-consumer channels will actually result in ...

South Carolina House lawmakers passed a bill restricting abortion pills on Wednesday. But some opponents of the legislation ...

Several commonly prescribed RA drugs can be self-injected at home, often using either a prefilled syringe or an auto-injector ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

As Super Bowl Sunday approaches, the battle off the field for advertisers to win over 120 million-plus viewers will be just ...